PARADIGM ASSET MANAGEMENT CO LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1034549 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,060,018

+$8,778 QoQ

Shares Held

1,700

+70.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#634

of 1,322 holders

Holding Since

Jun 2020

19 quarters on record

Voting authority Sole 65% Shared 0% None 35%

Healthcare · as of Jun 30, 2026

PARADIGM ASSET MANAGEMENT CO LLC holds $1,509,356 across 4 Biotechnology names. REGN ranks #1 (70.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	1,700	$1,060,018
2	VRTX	Vertex Pharmaceuticals Inc / Ma	650	$322,874
3	RPRX	Royalty Pharma plc	2,100	$117,747
4	FTRE	Fortrea Holdings Inc.	501	$8,717

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,060,018	1,700	+70.0%	Shares	Sole	2026-08-06
2024-09-30	$1,051,240	1,000	0.0%	Shares	Sole	2024-11-05
2024-06-30	$1,051,030	1,000	0.0%	Shares	Sole	2024-08-12
2024-03-31	$962,490	1,000	0.0%	Shares	Sole	2024-05-13
2023-12-31	$878,290	1,000	0.0%	Shares	Sole	2024-02-12
2023-09-30	$822,960	1,000	0.0%	Shares	Sole	2023-10-31
2023-06-30	$718,540	1,000	+233.3%	Shares	Sole	2023-08-14
2023-03-31	$246,501	300	0.0%	Shares	Sole	2023-05-11
2022-12-31	$216,447	300	-76.9%	Shares	Sole	2023-02-13
2022-09-30	$895,531	1,300	0.0%	Shares	Sole	2022-11-09
2022-06-30	$768,469	1,300	+30.0%	Shares	Sole	2022-08-08
2022-03-31	$698,420	1,000	0.0%	Shares	Sole	2022-05-05
2021-12-31	$631,520	1,000	0.0%	Shares	Sole	2022-02-14
2021-09-30	$605,180	1,000	-9.1%	Shares	Sole	2021-11-12
2021-06-30	$614,394	1,100	0.0%	Shares	Sole	2021-07-30
2021-03-31	$520,454	1,100	0.0%	Shares	Sole	2021-05-11
2020-12-31	$531,421	1,100	+10.0%	Shares	Sole	2021-02-12
2020-09-30	$559,780	1,000	0.0%	Shares	Sole	2020-11-13
2020-06-30	$623,650	1,000	—	Shares	Sole	2020-08-11
No filing history on record for this holder in this stock.